1. Home
  2. IMNM vs HLX Comparison

IMNM vs HLX Comparison

Compare IMNM & HLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMNM
  • HLX
  • Stock Information
  • Founded
  • IMNM 2006
  • HLX 1979
  • Country
  • IMNM United States
  • HLX United States
  • Employees
  • IMNM N/A
  • HLX N/A
  • Industry
  • IMNM Medicinal Chemicals and Botanical Products
  • HLX Oilfield Services/Equipment
  • Sector
  • IMNM Health Care
  • HLX Energy
  • Exchange
  • IMNM Nasdaq
  • HLX Nasdaq
  • Market Cap
  • IMNM 987.1M
  • HLX 983.3M
  • IPO Year
  • IMNM 2020
  • HLX 1997
  • Fundamental
  • Price
  • IMNM $13.83
  • HLX $6.64
  • Analyst Decision
  • IMNM Strong Buy
  • HLX Buy
  • Analyst Count
  • IMNM 9
  • HLX 3
  • Target Price
  • IMNM $24.89
  • HLX $12.00
  • AVG Volume (30 Days)
  • IMNM 2.0M
  • HLX 1.3M
  • Earning Date
  • IMNM 11-12-2025
  • HLX 10-22-2025
  • Dividend Yield
  • IMNM N/A
  • HLX N/A
  • EPS Growth
  • IMNM N/A
  • HLX N/A
  • EPS
  • IMNM N/A
  • HLX 0.33
  • Revenue
  • IMNM $12,589,000.00
  • HLX $1,277,904,000.00
  • Revenue This Year
  • IMNM N/A
  • HLX N/A
  • Revenue Next Year
  • IMNM $154.70
  • HLX $7.12
  • P/E Ratio
  • IMNM N/A
  • HLX $20.09
  • Revenue Growth
  • IMNM 16.74
  • HLX N/A
  • 52 Week Low
  • IMNM $5.15
  • HLX $5.52
  • 52 Week High
  • IMNM $15.13
  • HLX $11.48
  • Technical
  • Relative Strength Index (RSI)
  • IMNM 67.38
  • HLX 53.50
  • Support Level
  • IMNM $11.25
  • HLX $6.40
  • Resistance Level
  • IMNM $12.00
  • HLX $6.86
  • Average True Range (ATR)
  • IMNM 1.01
  • HLX 0.26
  • MACD
  • IMNM 0.40
  • HLX -0.01
  • Stochastic Oscillator
  • IMNM 87.06
  • HLX 52.69

About IMNM Immunome Inc.

Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.

About HLX Helix Energy Solutions Group Inc.

Helix Energy Solutions Group Inc is an offshore energy services company. It provides specialty services to the offshore energy industry, with an emphasis on well intervention and robotics operations. Helix provides services in deep water in the Gulf of Mexico, Brazil, the North Sea, Asia Pacific and West Africa regions. It has four segments: Well Intervention, Robotics, Shallow Water Abandonment and Production Facilities. the Well Intervention segment includes vessels and equipment used to perform well intervention services in the Gulf of Mexico, the North Sea and Brazil. It derives the majority of its revenue from the U.S.

Share on Social Networks: